Cardiology Grand Rounds Telecast Schedule for 2008-2009 Series

Live telecasts via UW Telehealth Services: 7:30 am – 8:30 am, third Friday of the month

from D-209 Health Sciences Bldg, University of Washington, Seattle, Washington.

Date	Speaker	Institute	Title	Host
Sep 19, 2008	Mickey Eisenberg	Univ. of Washington, Seattle, WA	Surviving Cardiac Arrest: Why Some Communities Succeed and Others Fail Learning Objectives: · Differentiate between patient, event, system, and therapy factors · Describe the frame of resuscitation · Define the most important factors associated with successful resuscitation	Page
Oct 17, 2008	Jeffrey Probstfield and Irl Hirsch	Univ. of Washington, Seattle, WA	The ACCORD Trial: What did we learn about glucose control in Type 2 Diabetes related to total mortality and macro-vascular CVD events? Learning Objectives: · The strategy used in ACCORD intensive glycemia group was associated with an increase in total mortality compared with that in the standard gylcemia strategy. 1a. There was also an increase in cardiovascular mortality. 1b. There was a decrease in all CVD events (Primary outcome). · Good glucose control was achieved and maintained using the proposed strategy (but not to goal). · Hypoglycemia, any single or combination of medications, was not associated with the increase in TM.	O’Brien
Nov 21, 2008	Jeffrey Probstfield	Univ. of Washington, Seattle, WA	The ONTARGET/TRANSCEND Results: RAAS Blockade – How Much is enough in the Prevention of CHD/CVD Events Learning Objectives: · RAAS blockade ha been established as appropriate prevention for CHDCVD Disease in those at high risk for ASCVD. · Previous trials established the importance of RAAS blockade with at least 2 ACD-Is; ONTARGET established the similarity of blockade with an ARB in participants without LV dysfunction. · Blockade with a combination of ACE-Is and ARBs does not further reduce the risk for CHD/CVD for those at high risk for ASCVD but who do not have CHF; use of the two classes of agents together may have risks without benefit. · RAAS blockade benefit is modest for those with ASCVD using an ARB to those with ACE-1 intolerance and without LV dysfunction	O’Brien
Dec 19, 2008	NO	DECEMBER	TELECAST	N/A
Jan 16, 2009	Richard Page	U. of Washington	Drug Therapy for AF: Is there hope on the horizon? Learning Objectives: · Understand the limitations of current drug therapy for AF · Recognize the potential benefit and options for less toxic drug therapy · Anticipate the potential for new drug therapy, based on recent clinical studies	O’Brien
Feb 20, 2009	Andrew Luks	U. of Washington	The Adult Congenital Heart Disease Patient at High Altitude Learning Objectives: · Describe the basic changes in cardiac physiology upon acute ascent to high altitude · Describe the main forms of high altitude illness that can affect all travelers to high altitude · Outline a basic approach to evaluating patients with congenital heart disease prior to high altitude travel	Stout
Mar 20, 2009	Kelley Branch	U. of Washington	Cardiac Computed Tomography: The Hope, Hype and Utility of a Burgeoning Technology Learning Objectives: · Describe the uses and potential complications of cardiac computed tomography. · Know the most appropriate patient populations in which to use cardiac CT. · Describe the current utility and the future studies of cardiac CT to guide patient care for atherosclerosis and cardiac disease.	Probstfield
Apr 17, 2009	Barry Greenberg	UCSD Medical Center	The Cardiorenal Syndrome Learning Objectives: · Describe the prevalence, risk factors and outcomes of the cardiorenal syndrome. · Summarize the pathophysiology of the cardiorenal syndrome. · Discuss new and emerging approaches to treatment.	O’Brien
May 15, 2009	William Weintraub	Jefferson University and Christiana Care Health System, Delaware	Beyond COURAGE: Towards More Evidence Based Coronary Care Learning Objectives: · Review current status of evidence in coronary care: testing and therapeutics · Use of guidelines · Efforts to make care more evidence based · How to translate care into the community	Probstfield
Jun 19, 2009	James Caldwell	U. of Washington	Imaging Cardiac Sympathetic Dysfunction Learning Objectives: · Have a basic understanding of the physiology of the cardiac sympathetic myo-neural interface in heart failure and sudden death · Understand how imaging can be used to evaluate the myo-neural interface · Understand what incremental information imaging provides in predicting outcome and response to therapy	O’Brien

Revised: 6/1/09